Golimumab - Janssen Biotech
At a glance
- Drug Originator Centocor; Medarex
- Drug Licenced by Janssen Pharmaceutical KK; Merck & Co; Mitsubishi Tanabe Pharma Corporation
- Drug Class Anti-inflammatories; Anti-TNF monoclonal antibodies; Antiasthmatics; Antihyperglycaemics; Antirheumatics; Cardiovascular therapies; Eye disorder therapies
- Mechanism of Action Tumour necrosis factor alpha inhibitors
- USA Patent Applicants CENTOCOR ORTHO BIOTECH INC; JANSSEN BIOTECH
- USA Patents 176
- BLAs 2
- International Patents 2,239
Disclaimer